Simplex Trading, LLC Annexon, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 25,830 shares of ANNX stock, worth $132,507. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,830

Holding current value

$132,507

% of portfolio

0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$4.49 - $7.2 $115,976 - $185,976	25,830 New	25,830 $152,000
Q1 2024 Apr 25, 2024	BUY	$4.03 - $7.81 $227,864 - $441,593	56,542 Added 837.29%	63,295 $453,000
Q4 2023 Feb 02, 2024	BUY	$1.63 - $4.63 $9,455 - $26,858	5,801 Added 609.35%	6,753 $30,000
Q3 2023 Nov 01, 2023	SELL	$2.13 - $3.84 $104,514 - $188,421	-49,068 Reduced 98.1%	952 $2,000
Q2 2023 Aug 04, 2023	BUY	$2.1 - $6.37 $84,004 - $254,812	40,002 Added 399.3%	50,020 $176,000
Q1 2023 Apr 27, 2023	SELL	$3.74 - $7.46 $129,935 - $259,175	-34,742 Reduced 77.62%	10,018 $38,000
Q4 2022 Feb 02, 2023	BUY	$4.56 - $6.61 $204,105 - $295,863	44,760 New	44,760 $231,000
Q2 2022 Aug 03, 2022	SELL	$2.11 - $4.06 $436 - $840	-207 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$2.73 - $11.94 $19,623 - $85,824	-7,188 Reduced 97.2%	207 $0
Q4 2021 Feb 23, 2022	BUY	$11.49 - $22.0 $84,968 - $162,690	7,395 New	7,395 $84,000

Others Institutions Holding ANNX

# of Institutions

146

Shares Held

102M

Call Options Held

178K

Put Options Held

159K

Bain Capital Life Sciences Investors, LLC Boston, MA

8.45M
Shares

$43.3 Million
8.98% of portfolio
Satter Management Co., L.P.

7.41M
Shares

$38 Million
76.44% of portfolio
Bvf Inc San Francisco, CA

7M
Shares

$35.9 Million
1.32% of portfolio
Black Rock Inc. New York, NY

6.59M
Shares

$33.8 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

6.43M
Shares

$33 Million
2.49% of portfolio

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $244M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account